Company Chemists' Association

Funding for the Medicines Supply Resilience Group (MSRG) has been provided by @abbvie , Accord and @ViatrisInc who have had no input into today’s reception in Parliament. Further details here: shorturl.at/rLtdN #MedicinesSupplyResilience

A great day of discussion and collaboration! Delegates from across the medicines supply chain connected to share ideas and resources for building resilience. Lots of ideas to take away. #SupplyChainResilience

@SadikAlHassanMP @APPGPharmacy @abbvie @ViatrisInc @harrison_mal @epilepsysociety @MHRAgovuk Delighted to hear from the Minister, Dr @zubirahmed who highlights the work the Department are undertaking to build supply chain resilience& the considerable work all parts of the chain are undertaking to ensure medicines reach patients in a timely manner. #SupplyChainResilience

@SadikAlHassanMP @APPGPharmacy @abbvie @ViatrisInc @harrison_mal @epilepsysociety Julian Beach, Interim Executive Director at @MHRAgovuk, speaks about the work the MHRA are undertaking to ensure quality, access and the highest-possible regulatory standards for the medicines supply chain. #SupplyChainResilience

Great to see so many people at the House of Commons for the Medicines Supply Resilience Group reception. Delegates are here to discuss how the medicines supply chain can be made to be more resilient, ensuring patients continue to access vital medicines. #SupplyChainResilience

It was good to meet @Sureena4WNE a member of the All-Party Pharmacy Group, to discuss the current funding challenges and what community pharmacy could deliver with additional investment, as outlined in our Prospectus: tinyurl.com/5cww7hvw

It was good to speak to @TheSun about the potential impact of a prolonged conflict involving Iran on the medicines supply chain. You can read the full piece here: lnkd.in/eQp-tPnx @LoukouEliza

Great to speak with @mimilaunder at @HSJnews for a discussion on her latest piece, “Will ICBs be vaccine hesitant?”, exploring important questions around ICB roles and vaccine commissioning. Read the article in full: lnkd.in/eAc_bG4E @NickThayer99

Meningitis and vaccination remain an important topic, especially in light of recent outbreaks. We were pleased to be featured in @theipaper discussing how community pharmacies can support vaccination efforts. shorturl.at/8VUjb @AlannahFrancis1

One in six pharmacies have cut weekend opening times: @NPA1921 @CCApharmacy @harrison_mal #PharmacyCrisis #HealthcareUK #AccessToMedicine #AandE #PatientCare #HealthcareNews pharmacy.biz/pharmacies-wee…

Community pharmacies’ retained margin is now £120m lower in real terms than a decade ago, highlighting growing financial pressure on the sector. @ComPharmEngland @CCApharmacy @DHSCgovuk @SKinnock #CommunityPharmacy #PharmacyFunding #NHS pharmacy.biz/community-phar…

Involve community pharmacies in weight loss treatment programmes: CCA @CCApharmacy @harrison_mal #ObesityTreatment #WeightLossDrugs #NHS #LondonHealth #PublicHealth #HealthcareAccess #HealthPolicy #MedicalNews #PatientSafety pharmacy.biz/community-phar…

We are delighted feature in this piece in @theipaper on how funding pressures are affecting community pharmacy. Sustained financial pressure is forcing tough decisions around services and opening hours. shorturl.at/pYhZC

Community pharmacies administered around 45 percent of all Covid vaccinations and over 4.2 million flu vaccinations during the Autumn campaign. @CCApharmacy #CommunityPharmacy #Vaccinations #FluShots #COVID19Vaccines pharmacy.biz/community-phar…

Both welcomed our 2025 Prospectus and the case for what community pharmacy can deliver with greater investment. Read our prospectus: tinyurl.com/CCAProspectus2… #CommunityPharmacy #PrimaryCare #Westminster #NHS

We discussed the ongoing funding pressures facing community pharmacy and how with the right investment pharmacies can strengthen primary care, boost NHS capacity and improve patient access.

Our Chief Executive Malcolm Harrison had great conversations in Westminster last week with Amanda Hack MP and Kevin McKenna MP.